Time for a neoadjuvant chemotherapy strategy in prostate cancer?
Walther
P J
PJ
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000639:trends; D020360:Neoadjuvant Therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018570:Risk Assessment
D018931:Antineoplastic Agents, Hormonal